| Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages JK Dowling, R Afzal, LJ Gearing, MP Cervantes-Silva, S Annett, GM Davis, ... Nature communications 12 (1), 1460, 2021 | 92 | 2021 |
| Nanomodulation of macrophages in multiple sclerosis FK Nally, C De Santi, CE McCoy Cells 8 (6), 543, 2019 | 68 | 2019 |
| Enhancing arginase 2 expression using target site blockers as a strategy to modulate macrophage phenotype C De Santi, FK Nally, R Afzal, CP Duffy, S Fitzsimons, SL Annett, ... Molecular Therapy-Nucleic Acids 29, 643-655, 2022 | 6 | 2022 |
| Compositions and methods for the treatment of diseases by enhancing arginase 2 in macrophages C Mccoy, C Santi, J Dowling, SA Cryan, R Afzal, F Nally, C Duffy US Patent App. 18/018,819, 2023 | | 2023 |
| Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers S Fitzsimons, M Muñoz-San Martín, F Nally, E Dillon, IA Fashina, ... Molecular Therapy-Nucleic Acids 33, 941-959, 2023 | | 2023 |
| Data fusion strategies for multi-modal classification of auto-immune dysregulation with vibrational spectroscopy MR Rafsanjani, R Muddiman, D Cullen, R Afzal, F Nally, C McCoy, ... European Conference on Biomedical Optics, 126270A, 2023 | | 2023 |
| In-vitro screening of immune response with FTIR spectroscopy in a miRNA murine knock out model R Muddiman, A Keogan, D Cullen, R Afzal, F Nally, C McCoy, AD Meade European Conference on Biomedical Optics, 1262708, 2023 | | 2023 |
| Nanomodulation of micrornas in macrophages Innate immunity in MS pathology and repair F Nally, V Lyons, C De Santi, SA Cryan, N Payne, C Mccoy MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 16-16, 2020 | | 2020 |
| Reduced arginase-2 is significant with IL-10 metabolic reprogramming of induced macrophages MP Cervantes-Silva, S Annett, GM Davis, C De Santi, N Assmann, ... | | |
